December 4, 2018 – Over the years, the Centers for Disease Control (CDC) and its partners have made major progress towards reducing lead exposure in the United States. But more work remains in preventing lead poisoning in US children and adults, according to a special supplement to the Journal of Public Health Management and Practice. The journal is published in the Lippincott portfolio by Wolters Kluwer.
While US population blood lead levels continue to decline, researchers, public health officials, and policymakers still face challenges in reaching national goals in the fight against lead poisoning, according to an introductory editorial by Adrienne S. Ettinger, ScD, MPH, Perri Z. Ruckart, MPH, and Timothy A. Dignam, PhD, MPH, of the CDC's Childhood Lead Poisoning Prevention Program. Published online today, the CDC-sponsored supplement collects new practice reports and perspectives on the continued challenges of preventing lead exposure in the US population.
Need for Further Advances in the National 'War on Lead'
The special issue of JPHMP "marks a turning point in the nation's 'war on lead' that has spanned over a century and highlights the accomplishments of the CDC and its state and local partners in preventing and controlling lead poisoning," Dr. Ettinger and coauthors write. Mainly due to policies aimed at controlling lead exposure in gasoline, paint, and consumer products, the percentage of American children with elevated blood levels has declined sharply over the past four decades.
Yet, as illustrated by the water contamination crisis in Flint, Michigan, lead exposure continues to be a major public health problem in the US. Recent estimates indicate that at least 500,000 one- to five-year-old children nationwide – 2.5 percent of children in that age range – still have elevated blood lead levels. "There is no known safe level of lead in children, and exposure to even low levels of lead can affect a child's growth and development," according to the authors.
The supplement presents 18 original practice reports and commentaries addressing the continued challenges of lead poisoning prevention. Topics include:
"The key to reaching the Healthy People 2020 goals for childhood lead poisoning prevention remains in sustained efforts by CDC and its partners to strengthen blood lead testing, surveillance, population-based interventions, and processes to identify lead-exposed children and link them to services with a focus on high-risk children and early interventions," Dr. Ettinger and coauthors conclude. "From this issue, it is clear that significant progress continues to be made in these areas and innovative ways to use data and resources are being developed and deployed."
Increased awareness of lead issues in the aftermath of Flint highlight opportunities for collaboration between CDC and other federal agencies as well as public‐private partnerships to help address lead elimination.
About Journal of Public Health Management and Practice
Journal of Public Health Management and Practice publishes articles which focus on evidence based public health practice and research. The journal is a bi-monthly peer-reviewed publication guided by a multidisciplinary editorial board of administrators, practitioners and scientists. Journal of Public Health Management and Practice publishes in a wide range of population health topics including research to practice; emergency preparedness; bioterrorism; infectious disease surveillance; environmental health; community health assessment, chronic disease prevention and health promotion, and academic-practice linkages.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information, software solutions, and services for the health, tax & accounting, finance, risk & compliance, and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer, headquartered in the Netherlands, reported 2017 annual revenues of €4.4 billion. The company serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide.
Wolters Kluwer Health is a leading global provider of trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.